Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA.
J Alzheimers Dis. 2009;18(1):211-30. doi: 10.3233/JAD-2009-1138.
Alzheimer's disease (AD) is characterized by plaques of amyloid-beta (Abeta) peptide, cleaved from amyloid-beta protein precursor (AbetaPP). Our hypothesis is that lifespan profiles of AD-associated mRNA and protein levels in monkeys would differ from mice and that differential lifespan expression profiles would be useful to understand human AD pathogenesis. We compared profiles of AbetaPP mRNA, AbetaPP protein, and Abeta levels in rodents and primates. We also tracked a transcriptional regulator of the AbetaPP gene, specificity protein 1 (SP1), and the beta amyloid precursor cleaving enzyme (BACE1). In mice, AbetaPP and SP1 mRNA and their protein products were elevated late in life; Abeta levels declined in old age. In monkeys, SP1, AbetaPP, and BACE1 mRNA declined in old age, while protein products and Abeta levels rose. Proteolytic processing in both species did not match production of Abeta. In primates, AbetaPP and SP1 mRNA levels coordinate, but an inverse relationship exists with corresponding protein products as well as Abeta levels. Comparison of human DNA and mRNA sequences to monkey and mouse counterparts revealed structural features that may explain differences in transcriptional and translational processing. These findings are important for selecting appropriate models for AD and other age-related diseases.
阿尔茨海默病(AD)的特征是淀粉样β(Abeta)肽斑块,该肽由淀粉样β蛋白前体(AbetaPP)切割而成。我们的假设是,猴子 AD 相关 mRNA 和蛋白质水平的寿命分布特征将与老鼠不同,并且差异寿命表达谱将有助于理解人类 AD 的发病机制。我们比较了啮齿动物和灵长类动物中 AbetaPP mRNA、AbetaPP 蛋白和 Abeta 水平的分布情况。我们还跟踪了 AbetaPP 基因的转录调节因子特异性蛋白 1(SP1)和β淀粉样前体切割酶(BACE1)。在小鼠中,AbetaPP 和 SP1 mRNA 及其蛋白产物在生命后期升高;老年时 Abeta 水平下降。在猴子中,SP1、AbetaPP 和 BACE1 mRNA 在老年时下降,而蛋白质产物和 Abeta 水平上升。两种物种的蛋白水解加工都与 Abeta 的产生不匹配。在灵长类动物中,AbetaPP 和 SP1 mRNA 水平协调,但与相应的蛋白质产物以及 Abeta 水平呈负相关。将人类 DNA 和 mRNA 序列与猴子和老鼠的对应序列进行比较,揭示了可能解释转录和翻译加工差异的结构特征。这些发现对于选择 AD 和其他与年龄相关的疾病的合适模型非常重要。